SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Scholar Rock Holding Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$40.24+0.34 (+0.85%)
Close on Oct 19, 2026
- Market cap
- $5.26B
- P/E (TTM)
- –
- Dividend yield
- –
Scholar Rock Holding Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -123.1%
Financial strength
- Current ratio
- 7.02
- Debt to equity
- 0.77
- Debt to assets
- 37.5%
- Cash to current liabilities
- 605.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 20.71
- Dividend yield
- –